|Bid||167.63 x 100|
|Ask||167.71 x 200|
|Day's Range||168.55 - 171.59|
|52 Week Range||158.54 - 209.22|
|PE Ratio (TTM)||173.70|
|Dividend & Yield||0.91 (0.55%)|
|1y Target Est||N/A|
Shire is also said to have hired its own defense advisers to ward off low bids.
The chief executive of Shire has questioned investors' valuation of his company, arguing the potential of a number of promising drugs has yet to be factored into its share price. Flemming Ornskov also ...